Lea Bentur1, Elias Hellou2, Aviv Goldbart3, Giora Pillar4, Einat Monovich2, Maram Salameh5, Inna Scherb6, Yedidia Bentur7. 1. Pediatric Pulmonology Unit, Meyer Children's Hospital, Rambam Health Care Campus, Haifa; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa. Electronic address: l_bentur@rambam.health.gov.il. 2. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa. 3. Department of Pediatrics, Faculty of Health Sciences, Ben Gurion University, Soroka University Medical Center, Beer-Sheva. 4. Department of Pediatrics, Carmel Medical Center, Haifa. 5. Pediatric Pulmonology Unit, Meyer Children's Hospital, Rambam Health Care Campus, Haifa; School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem. 6. Clinical Toxicology and Pharmacology Laboratory and Israel Poison Information Center, Rambam Health Care Campus, Haifa, Israel. 7. Pediatric Pulmonology Unit, Meyer Children's Hospital, Rambam Health Care Campus, Haifa; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa; Clinical Toxicology and Pharmacology Laboratory and Israel Poison Information Center, Rambam Health Care Campus, Haifa, Israel.
Abstract
BACKGROUND: Indoor group water-pipe tobacco smoking, commonly referred to as water-pipe smoking (WPS), especially in coffee shops, has gained worldwide popularity. We performed a comprehensive laboratory and clinical evaluation of the acute effects of active and passive indoor group WPS. METHODS: This comparative study evaluated pre- and post-30-min active and passive indoor group WPS. The outcome parameters were carboxyhemoglobin (COHb), nicotine, and cotinine levels; CBC count; and cardiorespiratory parameters. Exhaled breath condensate (EBC) cytokines and endothelial function (using the EndoPat device [Itamar Medical Ltd]) were measured only in active smokers. Statistical methods used were Student t test, Wilcoxon signed rank test, Fisher exact test, analysis of variance, and Newman-Keuls post hoc test where relevant. RESULTS: Sixty-two volunteers aged 24.9±6.2 years were included; 47 were active smokers, and 15 were passive smokers. COHb level increased postactive WPS (active smokers, 2.0%±2.9% vs 17.6%±8.8%; P<.00001); six subjects (12.7%) had a >25% increase, and two subjects (4.2%) had a >40% increase. Plasma nicotine level increased postactive WPS (active smokers, 1.2±4.3 ng/mL vs 18.8±13.9 ng/mL; P<.0001); plasma cotinine and urinary nicotine and cotinine levels also increased significantly. EBC IL-4, IL-5, IL-10, IL-17, and γ-interferon decreased significantly with postactive smoking; endothelial function did not change. WPS was associated with adverse cardiorespiratory changes. In passive smokers, COHb level increased (0.8%±0.25% vs 1.2%±0.8%, respectively, P=.003) as did respiratory rate. CONCLUSIONS: One session of active indoor group WPS resulted in significant increases in COHb and serum nicotine levels (eightfold and 18-fold, respectively) and was associated with adverse cardiorespiratory health effects. The minor effects found in passive smokers suggest that they too may be affected adversely by exposure to WPS. The results call for action to limit the continuing global spread of WPS in coffee shops. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT1237548; URL: www.clinicaltrials.gov.
BACKGROUND: Indoor group water-pipe tobacco smoking, commonly referred to as water-pipe smoking (WPS), especially in coffee shops, has gained worldwide popularity. We performed a comprehensive laboratory and clinical evaluation of the acute effects of active and passive indoor group WPS. METHODS: This comparative study evaluated pre- and post-30-min active and passive indoor group WPS. The outcome parameters were carboxyhemoglobin (COHb), nicotine, and cotinine levels; CBC count; and cardiorespiratory parameters. Exhaled breath condensate (EBC) cytokines and endothelial function (using the EndoPat device [Itamar Medical Ltd]) were measured only in active smokers. Statistical methods used were Student t test, Wilcoxon signed rank test, Fisher exact test, analysis of variance, and Newman-Keuls post hoc test where relevant. RESULTS: Sixty-two volunteers aged 24.9±6.2 years were included; 47 were active smokers, and 15 were passive smokers. COHb level increased postactive WPS (active smokers, 2.0%±2.9% vs 17.6%±8.8%; P<.00001); six subjects (12.7%) had a >25% increase, and two subjects (4.2%) had a >40% increase. Plasma nicotine level increased postactive WPS (active smokers, 1.2±4.3 ng/mL vs 18.8±13.9 ng/mL; P<.0001); plasma cotinine and urinary nicotine and cotinine levels also increased significantly. EBC IL-4, IL-5, IL-10, IL-17, and γ-interferon decreased significantly with postactive smoking; endothelial function did not change. WPS was associated with adverse cardiorespiratory changes. In passive smokers, COHb level increased (0.8%±0.25% vs 1.2%±0.8%, respectively, P=.003) as did respiratory rate. CONCLUSIONS: One session of active indoor group WPS resulted in significant increases in COHb and serum nicotine levels (eightfold and 18-fold, respectively) and was associated with adverse cardiorespiratory health effects. The minor effects found in passive smokers suggest that they too may be affected adversely by exposure to WPS. The results call for action to limit the continuing global spread of WPS in coffee shops. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT1237548; URL: www.clinicaltrials.gov.
Authors: Marielle C Brinkman; Hyoshin Kim; Sydney M Gordon; Robyn R Kroeger; Iza L Reyes; Dawn M Deojay; Caleb Chitwood; Timothy E Lane; Pamela I Clark Journal: Nicotine Tob Res Date: 2015-09-16 Impact factor: 4.244
Authors: Adriana Pérez; Arnold E Kuk; Meagan A Bluestein; Melissa B Harrell; Cheryl L Perry; Baojiang Chen Journal: Addict Behav Date: 2021-01-21 Impact factor: 3.913
Authors: Aruni Bhatnagar; Wasim Maziak; Thomas Eissenberg; Kenneth D Ward; George Thurston; Brian A King; Erin L Sutfin; Caroline O Cobb; Merlyn Griffiths; Larry B Goldstein; Mary Rezk-Hanna Journal: Circulation Date: 2019-05-07 Impact factor: 29.690
Authors: Marielle C Brinkman; Hyoshin Kim; Stephanie S Buehler; Anna M Adetona; Sydney M Gordon; Pamela I Clark Journal: Tob Control Date: 2018-10-30 Impact factor: 7.552
Authors: Nada O F Kassem; Noura O Kassem; Sandy Liles; Adam T Zarth; Sheila R Jackson; Reem M Daffa; Dale A Chatfield; Steven G Carmella; Stephen S Hecht; Melbourne F Hovell Journal: Nicotine Tob Res Date: 2018-03-06 Impact factor: 4.244